Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR

Clinical Chemistry

Volumn 43, Issue 11, 1997, Pages 2114-2120

  Révillion, Françoise ^a   Hornez, Louis ^a   Peyrat, Jean Philippe ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ONCOPROTEIN;

ARTICLE; BREAST CANCER; DNA DETERMINATION; DNA SEQUENCE; ENZYME IMMUNOASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030726496     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.11.2114     Document Type: Article

References (38)

1. Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-ertb B-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci U S A 1985;82:6497-501.
2. Coussens L, Yang-Feng TL, Chen Y-CLE, Gray A, McGrath J, Seeburgh P, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985;230:1132-9.
3. Shih C, Padhy LC, Murray M, Weinberg RA. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 1981;290:261-3.
4. Rajkumar T, Gullick WJ. The type I growth factor receptors in human breast cancer. Br Cancer Res Treat 1994;29:3-9.
5. Clark GM, McGuire WL. Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 1991;51:944-8.
6. Gullick WJ. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int J Cancer 1990;5:55-61.
7. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 1987;235:177-82.
8. Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 1989;49:2087-90.
9. May E, Mouriesse H, May-Levin F, Qian JF, May P, Delarue JC. Human breast cancer: identification of populations with high risk of early relapse in relation to both estrogen receptor status and c-erbB-2 overexpression. Br J Cancer 1990;62:430-5.
10. Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Association of c-erbB-2 protein overexpression with high rate of cell proliferation, increased risk of visceral metastasis, and poor long term survival in breast cancer. Int J Cancer 1991;49:650-5.
11. Tetu B, Brisson J. Prognostic significance of HER2/neu oncoprotein expression in node-positive breast cancer. Cancer 1994;73:2359-65.
12. Quenel N, Wafflart J, Bonichon F, de Mascarel I, Trojani M, Durand M, et al. The prognostic value of c-erbB-2 in primary breast carcinomas: a study on 942 cases. Br Cancer Res Treat 1995;35:283-91.
13. Wright C, Nicholson S, Angus B, Sainsbury JRC, Farndon J, Cairns J, et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer 1992;65:118-21.
14. Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Ryden S, et al. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer. Cancer Lett 1994;73:2978-84.
15. Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, et al. HER2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol 1992;10:599-605.
16. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Säve-Söderborgh J, Anbazhagan R, et al. Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 1992;10:1049-56.
17. Wright C, Cairns J, Cantwell BJ, Cattan AR, Hall AG, Harris AL, et al. Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S transferases. Br J Cancer 1992;65:271-4.
18. Stal O, Sullivan S, Wingreen S, Skoog L, Rutqvist LE, Carstensen JM, et al. c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer. Eur J Cancer 1995;31A:2185-90.
19. Press MF, Hung G, Godolphin W, Slamon DJ. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994;54:2771-7.
20. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Analysis of enzymatically amplified β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
21. Lönn U, Lönn S, Nylen U, Stenkvist B, Vennström B. Detection and temporal appearance of multiple copies of c-erbB-2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction. Breast Cancer Res Treat 1992;23:191-200.
22. Hubbard AL, Doris CP, Thompson AM, Chetty U, Anderson TJ. Critical determination of the frequency of c-erbB-2 amplification in breast cancer. Br J Cancer 1994;70:434-9.
23. Sestini R, Orlando C, Zentilin L, Gelmini S, Pinzani P, Bianchi S, et al. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem 1994;40:630-6.
24. Sestini R, Orlando C, Zentilin L, Lami D, Gelmini S, Pinzani P, et al. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. Clin Chem 1995;41:826-32.
25. Schneeberger C, Eder S, Speiser P, Zeillinger R. Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression. Anticancer Res 1996;16:849-52.
26. Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G. Overexpression of c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res 1988;3:21-31.
27. Slamon DJ, Goldophin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-12.
28. Dati C, Muraca R, Tazartes O, Antoniotti S, Perroteau I, Giai M, et al. C-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Int J Cancer 1991;47:833-8.
29. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 1987;6:605-10.
30. Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, Koehl C, et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci U S A 1987;84:9243-47.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
32. Gordon AW, Pegues JC, Johnson GR, Kannan B, Auersperg N, Stromber K. mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells. Cancer Lett 1995;89:63-71.
33. Mularoni A, Adessi GL, Arbez-Gindre F, Agnani G, Nicollier M. Competitive RT-PCR to quantify CFRT mRNA in human endometrium. Clin Chem 1996;42:1765-9.
34. Koscielny S, Daver A, Wafflart J, Goussard J, Ricolleau G, Rallet A, et al. Quantitative determination of c-erbB-2 oncoprotein in 1065 human breast tumours by an enzymoimmunoassay. Comparison with the clinico-biological parameters: a multicentric study [Abstract]. Eur J Cancer 1996;32A(Suppl 2):PP-1-5.
35. Jiang YH, Davidson LA, Lupton JR, Chapkin RS. Rapid competitive PCR: determination of relative gene expression in limiting tissue samples. Clin Chem 1996;42:227-31.
36. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A 1989;86:9717-21.
37. Cottrez F, Auriault C, Capron A, Groux H. Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res 1994;22:2712-3.
38. Delvenne CG, Winkler-Gol RA, Piccart MJ, Hustin J, Michaux D, Leclecq G, et al. Expression of c-erbb2, TGF-β1 and pS2 genes in primary human breast cancers. Eur J Cancer 1992;28:700-5.